Ezetimibe: all 213 studies that test it
Page 1 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- LDL Cholesterol Reduction Following Ezetimibe InitiationRecruitingNCT07839741Phase 4
- Ezetimibe for Arrhythmia Recurrence After AF AblationNot yet recruitingNCT07752758Phase 4
- Aggressive Lipid Lowering Therapy in ICI-Treated MelanomaRecruitingNCT07704918Not applicable
- Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary InterventionNot yet recruitingNCT07626840Not applicable
- A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular EventsNot yet recruitingNCT07474649Phase 3
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With AtherosclerosisRecruitingNCT07307989Phase 2
- To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaEnrolling by invitationNCT06646354Phase 3
- Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate CancerRecruitingNCT06437574Phase 2
- Cholesterol Lowering and Residual Risk in Diabetes, Type 1RecruitingNCT05641753Phase 4
- Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)Not yet recruitingNCT05587621Not applicable
- Effect of PCSK9 Inhibitors on Calcific Aortic Valve StenosisRecruitingNCT04968509Phase 3
- Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"RecruitingNCT04701242Not applicable
- Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMIRecruitingNCT04499859Phase 4
- Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS TherapyCompletedNCT05266586Phase 2Results posted
- Randomized Study of Obicetrapib in Combination With EzetimibeCompletedNCT04770389Phase 2Results posted
- Anti-inflammatory Effects of SimvastatinTerminatedNCT04638400Phase 4Results posted
- CHOlesterol Lowering and Residual Risk in Type 2 DiabetesCompletedNCT04369664Phase 4Results posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT03510884Phase 3Results posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedNCT03510715Phase 3Results posted
- A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin TherapyCompletedNCT03337308Phase 3Results posted
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CCompletedNCT03051100Phase 2Results posted
- Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis CTerminatedNCT02971033Phase 2Results posted
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT02890992Phase 2Results posted
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)CompletedNCT02748057Phase 3Results posted
- A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)CompletedNCT02741245Phase 3Results posted
- A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)CompletedNCT02550288Phase 3Results posted
- Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)CompletedNCT02476006Phase 3Results posted
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)CompletedNCT02460159Phase 3Results posted
- Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With DyslipidemiaCompletedNCT02304926Not applicableResults posted
- Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot StudyCompletedNCT01849068Phase 3Results posted
- Ezetimibe Versus Placebo in the Treatment of Non-alcoholic SteatohepatitisCompletedNCT01766713Phase 2Results posted
- A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)CompletedNCT01611883Phase 4Results posted
- Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant SubjectsCompletedNCT01375764Phase 2Results posted
- A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)CompletedNCT01370603Phase 3Results posted
- A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)CompletedNCT01370590Phase 3Results posted
- MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)CompletedNCT01154036Phase 3Results posted
- Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.CompletedNCT00988364Phase 4Results posted
- Ezetimibe in Patients Hypo-responsive to StatinsTerminatedNCT00965055Phase 3Results posted
- Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol TargetsCompletedNCT00908011Not applicableResults posted
- Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)CompletedNCT00871351Phase 4Results posted
- Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)CompletedNCT00867165Phase 3Results posted
- Phytosterols, Ezetimibe, and Cholesterol MetabolismCompletedNCT00863265Early Phase 1Results posted
- Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)CompletedNCT00862251Phase 3Results posted
- The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin StudyCompletedNCT00817843Phase 4Results posted
- Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2CompletedNCT00810303Phase 1Results posted
- Effects of Ezetimibe on the Absorption of Oxidized CholesterolCompletedNCT00794677Phase 4Results posted
- Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)CompletedNCT00762229Not applicableResults posted
- Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)TerminatedNCT00738972Phase 3Results posted
- Ezetimibe Reverse Cholesterol Transport (RCT) Pilot StudyCompletedNCT00701727Phase 4Results posted
- Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)CompletedNCT00687076Phase 4Results posted
- Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)CompletedNCT00654628Phase 4Results posted
- Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)CompletedNCT00654095Phase 3Results posted
- Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)CompletedNCT00653523Phase 3Results posted
- Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)CompletedNCT00652327Phase 4Results posted
- Comprehensive Magnetic Resonance of Peripheral Arterial DiseaseCompletedNCT00587678Not applicableResults posted
- Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRSCompletedNCT00559962Phase 2Results posted
- A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)CompletedNCT00535405Phase 3Results posted
- 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With EzetimibeCompletedNCT00525824Phase 3Results posted
- A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)CompletedNCT00496730Phase 3Results posted
- Effects of Statin and Ezetimibe Association on Kinetics of Artificial ChilomicronsCompletedNCT00481351Phase 4Results posted
- A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)CompletedNCT00479713Phase 3Results posted
- Antiplatelet and Anti-inflammatory Effects of Statins and EzetimibeCompletedNCT00474123Not applicableResults posted
- A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)CompletedNCT00462748Phase 3Results posted
- Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)CompletedNCT00442897Phase 4Results posted
- Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)CompletedNCT00423488Phase 3Results posted
- Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)CompletedNCT00418834Phase 3Results posted
- Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)CompletedNCT00413972Phase 3Results posted
- Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)CompletedNCT00409773Phase 3Results posted
- The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate HypercholesterolemiaCompletedNCT00405067Phase 2Results posted
- Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy SubjectsCompletedNCT00376246Phase 4Results posted
- Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)CompletedNCT00319449Phase 4Results posted
- To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)CompletedNCT00276484Phase 3Results posted
- To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)CompletedNCT00276458Phase 3Results posted
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)CompletedNCT00271817Phase 3Results posted
- A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid ReductionCompletedNCT00203476Phase 4Results posted
- Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)CompletedNCT00166504Phase 4Results posted
- Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)CompletedNCT00129402Phase 3Results posted
- Study of Heart and Renal ProtectionCompletedNCT00125593Phase 4Results posted
- A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)CompletedNCT00101439Phase 3Results posted
- An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)CompletedNCT00092677Phase 3Results posted
- Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High CholesterolCompletedNCT07564726Phase 3
- Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated TriglyceridesActive, not recruitingNCT07442630Phase 4
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and AtorvastatinCompletedNCT07268625Phase 1
- Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL CholesterolCompletedNCT07255820Phase 4
- A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and AtorvastatinCompletedNCT07235189Phase 1
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and RosuvastatinCompletedNCT07201545Phase 1
- Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and RosuvastatinCompletedNCT07182383Phase 1
- Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque StabilizationActive, not recruitingNCT06767345Phase 4
- A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult SubjectsCompletedNCT06547359Phase 1
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)CompletedNCT06112678Phase 1
- A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaCompletedNCT05930028Phase 3
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)CompletedNCT05749861Phase 1
- Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy SubjectsCompletedNCT05681247Phase 1
- Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348CompletedNCT05549401Phase 1
- Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome StudyStatus unknownNCT05263778Phase 4
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)CompletedNCT05192356Phase 1
- Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual ComponentsCompletedNCT04895059Phase 1
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)CompletedNCT04883658Phase 1
- Bioequivalence of Ezetimibe Tablets in Healthy SubjectsStatus unknownNCT04814589Phase 1
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348CompletedNCT04660370Phase 1